CAH - Cardinal Health, Inc.
NYSE
->
Healthcare
->
Medical Distribution
Dublin,
United States
Type: Equity
CAH price evolution
CAH
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4591 | $3854 | $4043 | $3990 |
| Short term investments | ||||
| Net receivables | $11788 | $11265 | $11344 | $10992 |
| Inventory | $18451 | $16987 | $15940 | $16620 |
| Total current assets | $37658 | $34688 | $33833 | $33497 |
| Long term investments | ||||
| Property, plant & equipment | $2446 | $2441 | $2462 | $2362 |
| Goodwill & intangible assets | $5371 | $5432 | $6081 | $6567 |
| Total noncurrent assets | $8915 | $9022 | $9584 | $9880 |
| Total investments | ||||
| Total assets | $46573 | $43710 | $43417 | $43377 |
| Current liabilities | ||||
| Accounts payable | $34259 | $31540 | $29813 | $29601 |
| Deferred revenue | ||||
| Short long term debt | $1188 | $788 | $792 | $26 |
| Total current liabilities | $38286 | $35065 | $33706 | $32503 |
| Long term debt | $3535 | $3890 | $3909 | $4708 |
| Total noncurrent liabilities | $11734 | $12135 | $12562 | $13092 |
| Total debt | $4723 | $4678 | $4701 | $4734 |
| Total liabilities | $50020 | $47200 | $46268 | $45595 |
| Shareholders' equity | ||||
| Retained earnings | -$425 | -$654 | -$534 | -$342 |
| Other shareholder equity | -$155 | -$165 | -$151 | -$142 |
| Total shareholder equity | -$3449 | -$3491 | -$2852 | -$2220 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4043 | $4717 | $3407 | $2771 |
| Short term investments | ||||
| Net receivables | $11344 | $10561 | $9103 | $8264 |
| Inventory | $15940 | $15636 | $14594 | $13198 |
| Total current assets | $33833 | $32935 | $31048 | $25940 |
| Long term investments | $27 | |||
| Property, plant & equipment | $2462 | $2361 | $2360 | $2366 |
| Goodwill & intangible assets | $6081 | $7629 | $10094 | $11275 |
| Total noncurrent assets | $9584 | $10943 | $13405 | $14826 |
| Total investments | ||||
| Total assets | $43417 | $43878 | $44453 | $40766 |
| Current liabilities | ||||
| Accounts payable | $29813 | $27128 | $23700 | $21374 |
| Deferred revenue | ||||
| Short long term debt | $792 | $580 | $871 | $10 |
| Total current liabilities | $33706 | $30550 | $27624 | $23615 |
| Long term debt | $3909 | $4735 | $5365 | $6765 |
| Total noncurrent liabilities | $12562 | $14034 | $15035 | $15359 |
| Total debt | $4701 | $5315 | $6236 | $6775 |
| Total liabilities | $46268 | $44584 | $42659 | $38974 |
| Shareholders' equity | ||||
| Retained earnings | -$534 | -$280 | $1205 | $1170 |
| Other shareholder equity | -$151 | -$114 | -$34 | -$104 |
| Total shareholder equity | -$2852 | -$709 | $1791 | $1789 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $57445 | $53453 | $50487 | |
| Cost of revenue | $55599 | $51626 | $48702 | |
| Gross Profit | $1846 | $1827 | $1785 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1283 | $1267 | $1179 | |
| Total operating expenses | $1348 | $1691 | $1213 | |
| Operating income | $498 | $136 | $572 | |
| Income from continuing operations | ||||
| EBIT | $497 | $138 | $570 | |
| Income tax expense | $136 | $187 | $197 | |
| Interest expense | $8 | $15 | $28 | |
| Net income | ||||
| Net income | $353 | -$64 | $345 | |
| Income (for common shares) | $353 | -$64 | $345 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $205012 | $181364 | $162467 | $152922 |
| Cost of revenue | $198123 | $174819 | $155689 | $146054 |
| Gross Profit | $6889 | $6545 | $6778 | $6868 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4834 | $4557 | $4533 | $4572 |
| Total operating expenses | $6158 | $7157 | $6259 | $10965 |
| Operating income | $731 | -$612 | $519 | -$4097 |
| Income from continuing operations | ||||
| EBIT | $730 | -$621 | $502 | -$3537 |
| Income tax expense | $376 | $163 | -$289 | -$79 |
| Interest expense | $93 | $149 | $180 | $238 |
| Net income | ||||
| Net income | $261 | -$933 | $611 | -$3696 |
| Income (for common shares) | $261 | -$933 | $611 | -$3696 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $353 | $5 | -$64 | $345 |
| Operating activities | ||||
| Depreciation | $175 | $172 | $176 | $175 |
| Business acquisitions & disposals | $9 | -$10 | ||
| Stock-based compensation | $28 | $29 | $27 | $21 |
| Total cash flows from operations | $1189 | $545 | $858 | $1361 |
| Investing activities | ||||
| Capital expenditures | -$113 | -$91 | -$207 | -$109 |
| Investments | -$1 | $28 | $1 | $28 |
| Total cash flows from investing | -$105 | -$63 | -$206 | -$91 |
| Financing activities | ||||
| Dividends paid | -$124 | -$131 | -$126 | -$128 |
| Sale and purchase of stock | -$250 | -$500 | -$500 | -$250 |
| Net borrowings | -$8 | -$7 | -$8 | -$558 |
| Total cash flows from financing | -$353 | -$666 | -$592 | -$934 |
| Effect of exchange rate | $6 | -$5 | -$7 | |
| Change in cash and equivalents | $737 | -$189 | $53 | $336 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $261 | -$933 | $611 | -$3696 |
| Operating activities | ||||
| Depreciation | $692 | $692 | $783 | $913 |
| Business acquisitions & disposals | -$10 | $901 | -$3 | $2 |
| Stock-based compensation | $96 | $81 | $89 | $90 |
| Total cash flows from operations | $2839 | $3122 | $2429 | $1960 |
| Investing activities | ||||
| Capital expenditures | -$469 | -$356 | -$400 | -$375 |
| Investments | $25 | $22 | $25 | $866 |
| Total cash flows from investing | -$454 | $567 | -$378 | $493 |
| Financing activities | ||||
| Dividends paid | -$525 | -$559 | -$573 | -$569 |
| Sale and purchase of stock | -$2000 | -$1000 | -$200 | -$350 |
| Net borrowings | -$579 | -$885 | -$570 | -$1401 |
| Total cash flows from financing | -$3051 | -$2463 | -$1317 | -$2200 |
| Effect of exchange rate | -$8 | -$25 | $11 | -$13 |
| Change in cash and equivalents | -$674 | $1310 | $636 | $240 |
News
Fundamentals
| Market cap | $25.86B |
|---|---|
| Enterprise value | $26.00B |
| Shares outstanding | 244.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -7.85 |
| Book/Share | -13.50 |
| Cash/Share | 18.82 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -16.22 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.98 |
| Quick ratio | 0.50 |